Available online on 15.06.2026 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright  © 2026 The   Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access Full Text Article   Review Article

Present Developments and Prospects for Natural Polymer-Based Drug Delivery Systems and Patient-Friendly Formulations

Shiv Kumar Srivastava 1Mahesh Prasad 1Shashi Shankar 1Anant Prakash Pandey 1Abhishek Singh 1Antesh Kumar Jha 1*

1 Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj Bypass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119.

Article Info:

_______________________________________________ Article History:

Received 22 March 2026  

Reviewed 11 May 2026  

Accepted 28 May 2026  

Published 15 June 2026  

_______________________________________________

Cite this article as:

For Correspondence:  

Abstract

_______________________________________________________________________________________________________________

Natural polymer-based drug delivery systems have gained significant attention in pharmaceutical research due to their biocompatibility, biodegradability, non-toxicity, affordability, and eco-friendly nature. Derived from plant, animal, microbial, and marine sources, these polymers play an important role in developing advanced and patient-friendly formulations. Commonly used natural polymers include sodium alginate, pectin, guar gum, xanthan gum, gelatin, chitosan, starch, and psyllium husk. Their unique properties such as swelling, gel formation, mucoadhesion, viscosity enhancement, and controlled drug release make them suitable for various drug delivery systems including fast-dissolving tablets, sustained-release formulations, hydrogels, nanoparticles, microbeads, and in situ gels. These systems improve therapeutic efficacy, enhance drug stability, reduce side effects, and increase patient compliance, especially in pediatric, geriatric, and dysphagic patients. The uses of natural polymers in pharmaceutical sciences have been further increased by recent developments in nanotechnology, smart hydrogels, mucoadhesive systems, targeted drug delivery, AI-assisted formulation optimization, and 3D printing. Their industrial use is nevertheless restricted by problems such batch-to-batch variability, microbiological contamination, inadequate mechanical strength, stability concerns, and lack of standardization, despite their many benefits. Therefore, maintaining product safety and reproducibility requires appropriate purification, quality control, and regulatory review. Future projections show that natural polymers will be increasingly integrated with intelligent drug delivery systems, green pharmaceutical technology, and personalized treatment. All things considered, natural polymers present a promising platform for the creation of pharmaceutical formulations that are patient-centered, safe, and sustainable and have a great deal of potential for therapeutic uses in the future.

Keywords: Drug delivery techniques; natural polymers; Biodegradable polymers; patient-friendly formulations; Smart hydrogels and regulated medication release

 


 

1. Introduction

Over the past few decades, drug delivery methods have undergone tremendous change with the goal of increasing patient compliance, reducing side effects, and boosting therapeutic efficacy. Pediatric, elderly, and dysphagic patients are among the specific populations whose therapeutic needs are frequently not met by conventional dosage forms. The need for patient-friendly formulations that offer better therapeutic results and simplicity of administration has grown as a result. Because of their distinct physicochemical and biological characteristics, natural polymers have become interesting pharmacological excipients. These polymers, which include materials like sodium alginate, pectin, guar gum, xanthan gum, chitosan, gelatin, starch, and Plantago ovata husk, come from plant, animal, microbiological, and marine sources. They are good choices for pharmaceutical applications due to their biodegradability, low toxicity, affordability, and environmental sustainability. 1,2,3,4 Natural polymers are widely used in hydrogels, nanoparticles, microbeads, fast-dissolving tablets, sustained-release tablets, and in situ gel systems. 5, 6 Their gel-forming capabilities, mucoadhesive qualities, and swelling behavior are crucial for regulating medication release and improving drug absorption. Plantago ovata husk was successfully used as a natural superdisintegrant in fast-dissolving glipizide tablets showing its exceptional swelling and disintegration properties. 6, 7 Similarly, hydrogel systems and microbeads based on sodium alginate have demonstrated great promise in applications involving controlled and prolonged drug delivery. 7, 8 Additionally, natural polymer-based in situ nasal gels have been studied for longer mucosal residence times and improved CNS drug delivery. 6

2. Classification of Natural Polymers

Because of their non-toxic nature, biocompatibility, biodegradability, and environmental friendliness, natural polymers are frequently utilized in pharmaceutical formulations. Natural sources include plants, animals, microbes, and marine life provide these polymers.9 Natural polymers are crucial to the development of cutting-edge drug delivery methods, patient compliance, medication stability, and drug release control in contemporary pharmaceutics. Natural polymers can be categorized as plant-based, animal-based, microbial, or marine based on where they come from. Each class has distinct functional and physicochemical characteristics that make them appropriate for a range of medicinal uses. 1 

 

2.1 Plant-Based Polymers

One of the most popular natural excipients in pharmaceutical formulations is a polymer generated from plants. They are affordable, readily accessible, renewable, and reasonably safe for human consumption. Seeds, fruits, roots, gum, and plants that produce mucilage are the principal sources of these polymers.10 Plant based natural polymers, their sources, key properties, pharmaceutical applications, and advantages are shown in table 1. 11-26


 

 

Table 1: Plant-Based Natural Polymers 

Plant Polymer

Source

Key Properties

Pharmaceutical Applications

Advantages

Starch

 

Obtained from corn, potato, rice, and wheat

Contains amylose and amylopectin; swelling and binding properties

Used as binder, disintegrant, and filler in tablets and capsules; modified starch used in sustained-release systems

Rapid tablet disintegration due to swelling property 

Guar Gum 

 

Seeds of Cyamopsis tetragonoloba

Thickening, binding, and gelling properties

Sustained-release tablets and colon-targeted drug delivery systems

Forms viscous gel barrier for controlled drug release; biodegradable and biocompatible

Pectin 

 

Citrus fruits and apple pomace

Gel-forming and mucoadhesive properties

Controlled-release systems, nasal gels, colon-targeted formulations, hydrogels, nanoparticles

Improves drug retention and provides biodegradable delivery systems

Sodium Alginate

 

Brown algae

Gel-forming ability in presence of calcium ions

Microbeads, hydrogels, floating systems, wound dressings, sustained-release formulations

Excellent biocompatibility and controlled drug release capability

Psyllium Husk 

 

Seeds of Plantago ovata

Highly swellable mucilage and water absorption properties

Fast dissolving tablets, sustained-release systems, gastrointestinal formulations

Acts as natural superdisintegrant and enhances drug dissolution

Xanthan Gum

 

Fermentation of sugars using Xanthomonas campestris

Thickening, stabilizing, and suspending properties

Oral liquids, gels, sustained-release matrix tablets

Improves viscosity and stability of formulations

Acacia Gum (Gum Arabic)

 

Stems and branches of Acacia species

Emulsifying, binding, and stabilizing properties

Suspensions, emulsions, lozenges, and tablet formulations

Enhances viscosity and formulation stability

 

 

 

 

 

2.2 Animal-Based Polymers

Animal- based natural polymers, their sources, key properties, pharmaceutical applications, and advantages are shown in table 2. 27-40  

Table 2: Animal-Based Natural Polymers

Animal Polymer

Source

Key Properties

Pharmaceutical/Biomedical Applications

Special Features/Advantages

Gelatin

 

Obtained by hydrolysis of collagen from animal skin, bones, and connective tissues

Excellent film-forming, gelling, and biocompatible properties

Hard and soft gelatin capsules, tablet coating, microencapsulation, wound healing formulations

Improves drug stability, bioavailability, and formulation flexibility

Collagen

 

Structural protein present in connective tissues

Biocompatible, biodegradable, low immunogenicity

Tissue engineering, wound healing, scaffolds, sponges, films, controlled drug delivery

Supports tissue regeneration and sustained drug release

Chitosan

 

Produced by deacetylation of chitin from shrimp and crab shells

Mucoadhesive, antimicrobial, permeation-enhancing, biodegradable

Nasal, ocular, oral, and transdermal drug delivery systems; nanoparticles and hydrogels

Enhances drug absorption and targeted drug delivery

Dextran

 

Produced by bacteria such as Leuconostoc mesenteroides

Branched polysaccharide with stabilizing and carrier properties

Plasma volume expander, nanoparticles, hydrogels, targeted drug delivery

Useful in tissue engineering and controlled drug delivery

Pullulan 

[

Produced by fungus Aureobasidium pullulans

Water-soluble, film-forming, oxygen barrier properties

Capsule formulations, oral films, edible coatings, pharmaceutical packaging

Improves film quality and packaging stability

Gellan Gum

 

Produced by Sphingomonas elodea through fermentation

Ion-sensitive gel-forming property

In situ gels, ophthalmic preparations, nasal formulations, sustained-release systems

Enhances drug residence time and bioavailability

 


 

3. Advantages of Natural Polymers in Drug Delivery

Concerns about toxicity, environmental effect, biocompatibility, and patient safety have led to a rise in interest in substituting natural polymers for synthetic excipients in recent years. Nowadays, a wide range of drug delivery devices, such as tablets, capsules, hydrogels, microbeads, nanoparticles, transdermal patches, and in situ gels, use natural polymers. 41 Natural polymers provide a number of advantages over synthetic polymers, including biocompatibility, biodegradability, non-toxicity, low cost, easy availability, eco-friendliness, better patient acceptability, fewer side effects, and increased medication stability. They are therefore good candidates for the creation of sophisticated and patient-friendly medication delivery systems. 3, 4, 9, 42

3.1. Biocompatibility

The outstanding biocompatibility of natural polymers is one of their main benefits. The capacity of a material to interact with biological tissues without producing dangerous or damaging reactions is referred to as biocompatibility. The human body often tolerates natural polymers well because they come from biological origins. Polymers that are extremely compatible with physiological systems include alginate, gelatin, chitosan, guar gum, pectin, and psyllium husk. When taken orally, topically, nasally, or by other methods, they do not cause noticeable irritation or inflammatory reactions. This characteristic is especially crucial when creating hydrogels, mucoadhesive drug delivery systems, tissue engineering scaffolds, and controlled-release systems. Additionally, biocompatibility lowers the possibility of tissue damage or allergic reactions and enhances the safety profile of pharmacological formulations. As a result, natural polymers are frequently chosen for pharmaceutical and biomedical applications that call for extended contact with biological tissues. 43-45  

3.2. Biodegradability

Natural polymers are biodegradable, which means that biological processes like enzyme degradation or microbial action can break them down into innocuous molecules. Because it keeps the body from accumulating polymer residues, this feature is very advantageous in pharmacological and biological applications. Biodegradable polymers break down over time into straightforward, non-toxic substances that the body can naturally get rid of. This property is particularly helpful in wound healing systems, microspheres, nanoparticles, and sustained-release implants where long-term retention of non-biodegradable materials could lead to issues. For instance, systems based on chitosan, gelatin, alginate, and starch can safely break down following drug release. Additionally, biodegradability makes it unnecessary to remove drug delivery devices surgically, which improves patient convenience and lowers treatment costs. . 46-48 

3.3. Non-Toxicity

Since natural polymers are derived from biological sources, they are typically regarded as harmless and non-toxic. The culinary, pharmaceutical, and medical industries have long employed the majority of natural polymers. Natural polymers typically show little toxicity, in contrast to some manufactured excipients that may yield hazardous breakdown products or irritating effects. This feature is crucial for formulations meant for elderly, pediatric, and chronically ill patients who need long-term medication therapy. Oral formulations, suspensions, emulsions, and topical medicines frequently contain polymers such sodium alginate, guar gum, acacia gum, and pectin, which are acknowledged as acceptable pharmaceutical excipients. Patient safety and therapeutic acceptance are greatly enhanced by their low toxicity. 9, 49 

3.4. Low Cost

The fact that natural polymers are less expensive than synthetic polymers is another significant benefit. The majority of natural polymers can be found in large quantities in renewable sources like seaweed, plants, and microbial fermentation. For instance, cheap substances like starch, guar gum, psyllium husk, and acacia gum can successfully substitute expensive synthetic excipients in a variety of formulations. Natural polymers' economic benefit promotes large-scale industrial production and makes medications more widely available to the general public. 50, 51 

3.5. Easy Availability

Natural polymers derived from sustainable natural resources are generally accessible. While marine polymers like alginate and carrageenan are extracted from seaweed, plant-derived polymers like starch, pectin, guar gum, and psyllium husk are readily acquired from agricultural sources. Natural polymers guarantee a steady supply of pharmaceutical raw materials due to their widespread availability. This promotes sustainable pharmaceutical production and lessens reliance on petrochemical industries. Research and development efforts in the pharmaceutical sciences are also made easier by easy access. Without major procurement challenges, researchers can easily investigate various natural polymers for novel drug delivery applications.   1,3,4, 9 

3.6. Eco-Friendly Nature

In today's pharmaceutical businesses, environmental sustainability has grown in importance. Because they are made from natural resources, renewable, and biodegradable, natural polymers are regarded as environmentally benign. Green chemistry and sustainable pharmaceutical practices are supported by the use of natural polymers. Their renewable source lessens the impact on the environment and encourages ecological equilibrium. As a result, in an effort to reduce their influence on the environment, the pharmaceutical industry is moving more and more toward natural excipients. 52, 53 

3.7. Better Patient Acceptability

Fast-dissolving tablets, oral films, chewable tablets, hydrogels, in situ gels, and sustained-release systems are just a few of the patient-friendly dosage forms that make extensive use of natural polymers. Natural polymers improve the flexibility, quick disintegration, and convenience of administration of fast-dissolving tablets and oral films without requiring water. They enhance the texture, binding qualities, and palatability of chewable pills, which increases patient compliance. Because of their biocompatibility, high water retention, and extended drug release, hydrogels and in situ gels make dosing less frequent and more comfortable. Natural polymers help regulate medication release over a longer duration in sustained-release systems, increasing therapeutic efficacy and reducing adverse effects. Pediatric, elderly, and dysphagic patients—who frequently have trouble swallowing traditional tablets and capsules—benefit most from these formulations. For instance, fast-dissolving pills made of psyllium husk and starch quickly dissolve in saliva, improving patient convenience and compliance. Therapeutic success is greatly influenced by improved palatability and ease of use. 54-56   

3.8. Reduced Side Effects

By regulating drug release and reducing variations in plasma drug concentration, natural polymers aid in the reduction of adverse drug reactions. By providing gradual and prolonged medication release, sustained-release and controlled-release systems made with natural polymers minimize side effects related to peak drug concentrations and decrease the frequency of administration. Additionally, mucoadhesive natural polymers enhance localized medication delivery while lowering systemic exposure and undesirable side effects. For example, topical hydrogels and nasal gels made with natural polymers offer tailored medication administration with less systemic toxicity. Furthermore, natural polymers have less negative formulation-related effects because they are non-toxic and less irritating. 55, 57, 58  

3.9. Improved Drug Stability

Pharmaceutical formulations can be made more chemically and physically stable by adding natural polymers. They shield medications against environmental deterioration brought on by light, moisture, air, and temperature changes. By creating protective barriers around drug molecules, hydrogels, microbeads, nanoparticles, and matrix systems made with natural polymers increase therapeutic stability and shelf life. Sensitive medications, proteins, and peptides are frequently encapsulated and stabilized using polymers including alginate, pectin, gelatin, and chitosan. Enhanced drug stability lowers the possibility of degradation during storage and delivery and guarantees consistent therapeutic efficacy. 9, 59, 60 

4. Natural Polymer-Based Drug Delivery Systems

By offering safe, biodegradable, and patient-friendly substitutes for synthetic excipients, natural polymers have completely transformed the production of pharmaceutical formulations. They are ideal for sophisticated drug delivery systems because of their special physicochemical characteristics, which include the capacity for regulated drug release, mucoadhesion, gel formation, swelling, and viscosity increase. Formulations based on natural polymers increase patient compliance, decrease side effects, and improve therapeutic efficacy. The most significant drug delivery systems created with natural polymers include hydrogels, in situ gels, microbeads, fast-dissolving tablets, and sustained-release systems. 3, 9, 61 Natural polymer- based drug delivery systems are shown in Table 3. 56, 62-65


 

 

Table 3: Natural polymer- based drug delivery systems

Drug Delivery System

Definition / Principle

Natural Polymers Used

Mechanism of Action

Advantages

Fast Dissolving Tablets (FDTs)

 

Solid dosage forms that rapidly disintegrate in saliva without water.

Plantago ovata husk (psyllium), guar gum, sodium alginate, xanthan gum, starch derivatives

Swelling, wicking, water absorption, particle repulsion

Rapid onset of action, improved patient compliance, easy administration, enhanced bioavailability, reduced choking risk

Sustained Release Systems

 

Formulations designed to release drugs slowly over an extended period.

HPMC, sodium alginate, guar gum, pectin, xanthan gum

Polymer swelling, gel layer formation, diffusion, matrix erosion

Reduced dosing frequency, stable plasma concentration, reduced side effects, improved adherence

Microbeads / Microspheres 

Multiparticulate systems for controlled and site-specific drug delivery.

Sodium alginate, starch, gelatin, chitosan

Ionotropic gelation, encapsulation, controlled diffusion

Improved stability, targeted delivery, reduced gastric irritation, controlled drug release

In Situ Gel Systems 

Liquid formulations that convert into gels under physiological conditions.

Gellan gum, pectin, sodium alginate, chitosan, xanthan gum

Sol-to-gel transition triggered by pH, ions, or temperature

Prolonged retention, enhanced bioavailability, sustained release, improved mucosal adhesion

Hydrogel Systems

 

Three-dimensional cross-linked polymeric networks capable of absorbing large amounts of water.

Alginate, chitosan, pectin, gelatin, carrageenan

Swelling-controlled diffusion and polymer relaxation

High biocompatibility, soft structure, excellent swelling, improved patient comfort

 

 


 

5. Patient-Friendly Formulations

The goal of patient-friendly formulations is to increase adherence, acceptability, and convenience of administration, as explained in Table 4 given below:  66-69

Table 4: Patient-Friendly Formulations

Patient Group

Challenges

Natural Polymers Used

Suitable Formulations

Major Advantages

Pediatric Patients

Difficulty swallowing, variable dosing, fear of medication

Starch, guar gum, sodium alginate, pectin, xanthan gum, psyllium husk

Orodispersible tablets, suspensions, chewable tablets, oral liquids

Easy administration, rapid disintegration, improved palatability and compliance

Geriatric Patients 

Dysphagia, reduced saliva, polypharmacy, poor adherence

Psyllium husk, sodium alginate, guar gum, xanthan gum

Fast dissolving tablets, sustained-release systems

Reduced choking risk, prolonged drug release, better convenience

Dysphagic Patients

Difficulty swallowing tablets and capsules

Pectin, xanthan gum, sodium alginate, gelatin

Oral films, hydrogels, suspensions, in situ gels

Smooth swallowing, enhanced comfort, improved drug absorption

 

6. Recent Advances in natural polymer

Recent developments in natural polymer research are shown in Table 5: 44, 70-76 

Table 5: Recent developments in natural polymer

Recent Advancement

Role of Natural Polymers

Applications

Advantages

Nanotechnology-Based Systems

Chitosan, alginate, gelatin, dextran, and pectin are used in nanoparticle preparation due to their biocompatibility and controlled-release properties.

Cancer therapy, CNS drug delivery, vaccine delivery, oral peptide delivery

Improved bioavailability, targeted delivery, reduced toxicity, controlled release

Nanostructured Lipid Carriers (NLCs)

Natural polymers such as chitosan and alginate are used as coating materials to improve mucoadhesion and sustained release.

Topical delivery, ocular delivery, antifungal therapy, brain targeting

Enhanced drug stability, prolonged release, better skin penetration

Smart Hydrogels

 

Alginate, gelatin, carrageenan, and pectin form responsive hydrogel networks with high swelling capacity.

Controlled drug delivery, wound healing, tissue engineering, injectable systems

Site-specific release, improved patient comfort, prolonged release

Mucoadhesive Drug Delivery

 

Chitosan, sodium alginate, pectin, and xanthan gum improve adhesion and drug absorption.

Nasal delivery, buccal systems, ocular formulations, vaginal delivery

Enhanced bioavailability, prolonged retention, reduced dosing frequency

AI-Assisted Formulation Optimization

AI helps optimize polymer concentration, swelling behavior, and drug release characteristics of natural polymer-based systems.

Tablet optimization, hydrogel development, nanoparticle formulation

Reduced development time, improved reproducibility, better quality control

3D Printed Pharmaceutical Dosage Forms

Alginate, gelatin, and chitosan are used as printable biomaterials because of their gel-forming properties.

Personalized medicine, pediatric dosage forms, implants, controlled-release tablets

Customized dosing, patient-centric therapy, flexible drug release

Targeted Drug Delivery Systems

Natural polymers are used in nanoparticles, microspheres, and hydrogels for targeted delivery.

Cancer therapy, brain targeting, colon-targeted delivery

Reduced side effects, improved efficacy, site-specific delivery

Personalized Medicine

 

Natural polymers support flexible dosing and patient-friendly dosage form development.

Pediatric formulations, geriatric dosage forms, chronic disease management

Better therapeutic outcomes, improved adherence, reduced adverse effects

 

7. Challenges Associated with Natural Polymers

Challenges Associated with Natural Polymers are explained in Table 6. 4, 55, 77- 80 

Table 6: Challenges Associated with Natural Polymers

Challenge

Explanation

Impact on Formulations

Possible Solution

Batch-to-Batch Variability

 

Natural polymers vary due to differences in climate, cultivation, harvesting, and extraction methods.

May affect viscosity, swelling, drug release, and product consistency.

Standardization of raw materials and strict quality control measures.

Microbial Contamination

 

Natural polymers are susceptible to microbial growth during storage and processing.

Can reduce shelf life, stability, and patient safety.

Sterilization, preservatives, and proper storage conditions.

Poor Mechanical Strength

 

Many natural polymers have weak tensile and structural properties.

Tablets, films, and hydrogels may become fragile or unstable.

Cross-linking, polymer blending, and chemical modification.

Stability Issues

 

Environmental factors such as moisture, heat, and pH can alter polymer properties.

May affect drug stability and formulation performance during storage.

Use of stabilizers, protective packaging, and optimized storage conditions.

Limited Reproducibility

 

Natural variability makes consistent formulation performance difficult.

Creates challenges in large-scale manufacturing and quality assurance.

Process optimization and advanced analytical characterization techniques.

Need for Standardization and Purification 

Natural polymers may contain impurities and unwanted residues.

Impurities can affect safety, efficacy, and regulatory acceptance.

Purification, characterization, and regulatory quality evaluation.

 

8. Regulatory Considerations

Regulatory Considerations of natural polymers are given in Table 7. 81-85  

Table 7: Challenges Associated with Natural Polymers

Regulatory Consideration

Explanation

Importance

Safety Evaluation

 

Assessment of irritation, allergenicity, and biocompatibility of natural polymers.

Ensures patient safety and suitability for long-term use.

Toxicity Studies

 

Acute and chronic toxicity testing of natural excipients.

Identifies toxic effects and safe dosage limits.

Quality Control

 

Testing for purity, viscosity, microbial load, and physicochemical properties.

Maintains formulation stability and batch consistency.

Standardization

 

Standardization of extraction and processing methods.

Reduces batch variability and improves reproducibility.

Good Manufacturing Practices (GMP)

Regulation of manufacturing, packaging, and storage processes.

Prevents contamination and ensures product quality.

Pharmacopoeial Compliance 

Compliance with standards of IP, USP, BP, and EP.

Confirms identity, purity, and pharmaceutical acceptability.

 

 


 

9. Future Perspectives 

Due to the quick developments in biotechnology, nanotechnology, pharmaceutical engineering, and material sciences, the future of natural polymer-based drug delivery systems seems quite bright. For the creation of safer, biodegradable, and patient-friendly pharmaceutical formulations, natural polymers like alginate, chitosan, gelatin, pectin, guar gum, and xanthan gum are being investigated more and more. They are ideal for cutting-edge therapeutic applications due to their special qualities, which include biocompatibility, biodegradability, low toxicity, and eco-friendliness. Natural polymer-based systems are anticipated to play a significant role in upcoming pharmaceutical advances as healthcare systems continue to shift toward personalized and precision treatment. 4, 86   AI-driven formulation design is one of the most significant areas of future research. By facilitating quick formulation parameter prediction and optimization, artificial intelligence (AI) and machine learning technologies are revolutionizing pharmaceutical research. Because drug release patterns are greatly influenced by polymer concentration, swelling behavior, viscosity, and cross-linking, natural polymer-based systems are frequently complex. Large experimental datasets can be analyzed by AI tools to find the best polymer and formulation variable combinations. This method lowers experimental mistakes, speeds up formulation development, and enhances reproducibility. Future controlled-release systems, hydrogels, nanoparticles, and patient-specific medications may benefit from automated formulation development and predictive modeling made possible by AI-assisted technologies. 73, 87, 88 Personalized medicine, which focuses on adjusting treatment based on each patient's unique physiological condition, genetic profile, age, and disease state, is another exciting field. Because they provide adjustable dosing, controlled drug release, and dosage form customisation, natural polymers are ideal for individualized medication delivery. Patient-specific tablets, implants, oral films, and hydrogels can be created by combining natural polymer-based biomaterials with technologies like 3D printing. For patients who need customized therapy and dose modifications, such as children, the elderly, and those with chronic illnesses, personalized formulations are very helpful. 74, 89 Another area of pharmaceutical sciences that is expanding quickly is the creation of smart responsive hydrogels. Smart hydrogels are stimuli-responsive systems that can respond to light, enzymes, temperature, pH, and ionic concentration. Because of their superior swelling and gel-forming qualities, natural polymers including alginate, chitosan, gelatin, and pectin are being used more and more to create these sophisticated hydrogel systems. Drugs can be selectively released at the target site via smart hydrogels, increasing therapeutic efficacy and lowering systemic side effects. Injectable smart hydrogels with tissue regeneration, self-healing, and real-time controlled medication release for cancer treatment and chronic illnesses could result from future study. 90, 91   It is anticipated that biopolymer engineering would greatly increase the use of natural polymers in medication delivery systems. Natural polymers have many benefits, but their medicinal usage may be limited by issues like instability, batch variability, and inadequate mechanical strength. To enhance the functionality and performance of polymers, contemporary biopolymer engineering techniques such as chemical modification, grafting, cross-linking, and copolymerization are being used. Future drug delivery systems may be more effective thanks to engineered biopolymers with improved stability, mucoadhesion, mechanical strength, and targeting capability. 92, 93The advancement of green pharmaceutical technologies is another significant future path. Growing industrial waste and environmental degradation have made environmental sustainability a top priority for the pharmaceutical industry. Natural polymers are biodegradable and renewable materials that help in environmentally responsible pharmaceutical production. Green extraction techniques, solvent-free processing, ecologically safe manufacturing techniques, and sustainable packaging are anticipated to be the main emphasis of future pharmaceutical technology. Using natural polymers can help produce pharmaceuticals in an environmentally friendly manner and lessen reliance on artificial petrochemical excipients.52 Commercial patient-centric dosage form development is also becoming more and more crucial. Enhancing patient convenience, treatment compliance, and therapeutic results are key components of contemporary healthcare systems. When creating patient-friendly formulations including oral films, hydrogels, chewable tablets, fast-dissolving tablets, sustained-release systems, and in situ gels, natural polymers is a great choice. In order to create extremely effective and practical medication delivery methods, future dosage forms may incorporate a variety of technologies, including nanotechnology, AI optimization, and smart polymers. Particularly for dysphagic, elderly, and pediatric patients, these sophisticated formulations can enhance drug adherence.  94, 95

10. Conclusion

In order to create patient-friendly formulations and sophisticated drug delivery systems, natural polymers have become extremely valuable pharmaceutical excipients. They are good substitutes for synthetic polymers because to their biocompatibility, biodegradability, non-toxicity, cost, and environmental sustainability. Alginate, chitosan, gelatin, guar gum, pectin, xanthan gum, and psyllium husk are examples of natural polymers that have shown great promise in hydrogels, nanoparticles, microbeads, fast-dissolving tablets, sustained-release systems, and in situ gel formulations. Particularly for pediatric, elderly, and dysphagic patients, these systems improve therapeutic efficacy, increase drug stability, decrease side effects, and boost patient compliance. The use of natural polymers in contemporary pharmaceutics has been reinforced by recent developments in nanotechnology, smart hydrogels, AI-assisted formulation creation, targeted drug delivery, and 3D printing. However, additional standardization and regulatory control are needed to address difficulties such batch variability, microbiological contamination, low mechanical strength, and stability problems. To optimize the clinical and commercial potential of natural polymer-based drug delivery, future research should concentrate on biopolymer engineering, customized medicine, and green pharmaceutical technologies.

Authors Contributions: 

Shiv Kumar Srivastava: Critical Analysis & Interpretation

Mahesh Prasad: Conceptualization

Shashi Shankar: Literature Search & Data Collection

Anant Prakash Pandey: Literature Search & Data Collection

Abhishek Kumar Singh: Literature Search & Data Collection

Antesh Kumar Jha: Writing – Original Draft

Funding sources: This paper did not receive any grant from funding agencies in the public, commercial, or not-for-profit sectors.

Competing interests/Conflicts of interest: Not Any

Ethical Approval: Not applicable

References:

1. Ezike TC, Okpala US, Onoja UL, Nwike CP, Ezeako EC, Okpara OJ, et al. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023;9(6):e17488. https://doi.org/10.1016/j.heliyon.2023.e17488 PMid:37416680 PMCid:PMC10320272

2. Adepu S, Ramakrishna S. Controlled drug delivery systems: Current status and future directions. Molecules. 2021;26(19):5905. https://doi.org/10.3390/molecules26195905 PMid:34641447 PMCid:PMC8512302

3. Jha AK, Srivastava SK, Prasad M, Shankar S, Singh AK, Pandey AP. Rare plant-derived polysaccharides as next-generation drug delivery carriers: Opportunities, challenges, and future perspectives. J Pharm Res Int. 2026;38(5):1-15. https://doi.org/10.9734/jpri/2026/v38i57835

4. Jha AK, Prasad M, Shankar S, Pandey AP, Singh AK, Srivastava SK. A thorough analysis of natural polymers as functional excipients in contemporary pharmaceutical formulations. J Drug Deliv Ther. 2026;16(4):165-176. https://doi.org/10.22270/jddt.v16i4.7688

5. Srivastava SK, Prasad M, Shankar S, Pandey AP, Jha AK. From molecules to medicine: Nanotechnology transforming modern therapeutics. J Drug Deliv Ther. 2026;16(2):29-40. https://doi.org/10.22270/jddt.v16i2.7557

6.     Jha AK, Prasad M, Srivastava SK. Design and characterization of doxepin in-situ nasal gel using pectin as a bio-compatible matrix. Int J Pharm Compd. 2026;30(1):42-56.

7. Srivastava SK, Prasad M, Shankar S, Pandey AP, Singh AK, Jha AK. Alginate-based hydrogels and particulate systems: Preparation techniques, adaptations, and utilizations in pharmaceutical delivery and biomedical research. J Drug Deliv Ther. 2026;16(3):180-191. https://doi.org/10.22270/jddt.v16i3.7627

8. Cao J, Wu B, Yuan P, Liu Y, Hu C. Research progress of sodium alginate-based hydrogels in biomedical engineering. Gels. 2025;11(9):758. https://doi.org/10.3390/gels11090758 PMid:41002532 PMCid:PMC12469324

9. Satchanska G, Davidova S, Petrov PD. Natural and synthetic polymers for biomedical and environmental applications. Polymers. 2024;16(8):1159. https://doi.org/10.3390/polym16081159 PMid:38675078 PMCid:PMC11055061

10. Beneke CE, Viljoen AM, Hamman JH. Polymeric plant-derived excipients in drug delivery. Molecules. 2009;14(7):2602-2620. doi:10.3390/molecules14072602. https://doi.org/10.3390/molecules14072602 PMid:19633627 PMCid:PMC6255379

11. Kapoor DU, Pareek A, Sharma M, Prajapati BG, Suttiruengwong S, Sriamornsak P. Exploring starch-based excipients in pharmaceutical formulations: Versatile applications and future perspectives. Eur J Pharm Biopharm. 2025;212:114727. https://doi.org/10.1016/j.ejpb.2025.114727 PMid:40286879

12. Račić A, Gatarić B, Topić Vučenović V, Stojmenovski A. Polysaccharide-based drug delivery systems in pediatrics: Addressing age-specific challenges and therapeutic applications. Polysaccharides. 2025;6:108. https://doi.org/10.3390/polysaccharides6040108

13. Tahmouzi S, Meftahizadeh H, Eyshi S, Mahmoudzadeh A, Alizadeh B, Mollakhalili-Meybodi N, et al. Application of guar (Cyamopsis tetragonoloba L.) gum in food technologies: A review of properties and mechanisms of action. Food Sci Nutr. 2023;11(9):4869-4897. https://doi.org/10.1002/fsn3.3383 PMid:37701200 PMCid:PMC10494631

14.  Jha AK. Formulation and optimization of sustained-release matrix tablets of metoprolol succinate using HPMC and guar gum: A factorial design and response surface approach. Int J Creat Res Thoughts. 2025;13(10):c417-c429.

15. Kedir WM, Deresa EM, Diriba TF. Pharmaceutical and drug delivery applications of pectin and its modified nanocomposites. Heliyon. 2022;8(9):e10654. https://doi.org/10.1016/j.heliyon.2022.e10654 PMid:36164543 PMCid:PMC9508417

16.  Sachan N, Pushkar S, Jha A, Bhattacharya A. Sodium alginate: The wonder polymer for controlled drug delivery. J Pharm Res. 2009;2(8):1191-1199.

17. Jha AK, Bhattacharya A. Preparation and evaluation of sweet potato starch blended sodium alginate microbeads. Asian J Pharm. 2009;3(4):299-303. https://doi.org/10.4103/0973-8398.59955

18. Jha AK, Chetia D. In vitro-in vivo performance evaluation of treated Plantago ovata husk based fast dissolving tablets of glipizide: Flashtab technology. Asian J Pharm. 2014;8(4):250-258. https://doi.org/10.4103/0973-8398.143938

19. Jha AK, Chetia D. Development of natural gum based fast disintegrating tablets of glipizide. Asian J Pharm. 2012;6(4):282-288. https://doi.org/10.4103/0973-8398.107564

20. Jha AK, Chetia D. Development and statistical analysis of glipizide-loaded fast dissolving tablets using Plantago ovata husk as superdisintegrant. Int J Pharm Compd. 2011;15(6):312-325. https://doi.org/10.4103/0973-8398.97106

21. Jha AK, Chetia D. Formulation and evaluation of glipizide-loaded fast-dissolving tablets using husk of Plantago ovata as a superdisintegrant. Asian J Pharm. 2011;5(4):198-202. https://doi.org/10.4103/0973-8398.97106

22. Jha AK, Srivastava SK, Srivastav RK, Tiwari AK, Tiwari A, Prasad M. Exploring the multifaceted benefits of psyllium husk: A review of its pharmaceutical, pharmacological, and nutritional properties. Int J Creat Res Thoughts. 2025;13(1):g498-g508. https://doi.org/10.56975/ijcrt.v13i1.276355

23.  Srivastava SK, Srivastav RK, Tiwari AK, Tiwari A, Jha AK, Prasad M. Factorial design analysis of the effects of formulation variables on glipizide-loaded fast dissolving tablets. Int J All Res Educ Sci Methods. 2025;13(3):2787-2792.

24. Layek B. A comprehensive review of xanthan gum-based oral drug delivery systems. Int J Mol Sci. 2024;25(18):10143. https://doi.org/10.3390/ijms251810143 PMid:39337626 PMCid:PMC11431853

25. Desta KH, Tadese E, Molla F. Physicochemical characterization and evaluation of the binding effect of Acacia etbaica Schweinf gum in granule and tablet formulations. Biomed Res Int. 2021;2021:5571507. https://doi.org/10.1155/2021/5571507 PMid:34692833 PMCid:PMC8531771

26. Mohammadinejad R, Kumar A, Ranjbar-Mohammadi M, Ashrafizadeh M, Han SS, Khang G, et al. Recent advances in natural gum-based biomaterials for tissue engineering and regenerative medicine: A review. Polymers. 2020;12(1):176. https://doi.org/10.3390/polym12010176 PMid:31936590 PMCid:PMC7022386

27. Cahyadi S, Djawad K, Widita W, Wahab S, Azis NRF. Exploring the role of gelatins in accelerating wound healing: A recent update. J Wound Manag Res. 2025;21(3):115-126. https://doi.org/10.22467/jwmr.2025.03321

28. Mikhailov OV. Gelatin as it is: History and modernity. Int J Mol Sci. 2023;24(4):3583. https://doi.org/10.3390/ijms24043583 PMid:36834993 PMCid:PMC9963746

29. Emam AN. Collagen and collagen-derived materials: Synthesis, structure, classification, fundamental properties and biomedical applications. Discov Appl Sci. 2025;7:1114. https://doi.org/10.1007/s42452-025-07780-x

30. Wosicka-Frąckowiak H, Poniedziałek K, Woźny S, Kuprianowicz M, Nyga M, Jadach B, et al. Collagen and its derivatives serving biomedical purposes: A review. Polymers. 2024;16:2668. https://doi.org/10.3390/polym16182668 PMid:39339133 PMCid:PMC11435467

31. Edo GI, Yousif E, Al-Mashhadani MH. Chitosan: An overview of biological activities, derivatives, properties, and current advancements in biomedical applications. Carbohydr Res. 2024;542:109199. https://doi.org/10.1016/j.carres.2024.109199 PMid:38944980

32. Desai N, Rana D, Salave S, Gupta R, Patel P, Karunakaran B, et al. Chitosan: A potential biopolymer in drug delivery and biomedical applications. Pharmaceutics. 2023;15:1313. https://doi.org/10.3390/pharmaceutics15041313 PMid:37111795 PMCid:PMC10144389

33. Srivastava SK, Prasad M, Jha AK. Development and evaluation of thermo triggered in situ nasal gel of selegiline for depressive disorders: In vitro, in vivo and ex vivo characterization. Res J Pharm Technol. 2022;15(4):1424-1430. https://doi.org/10.52711/0974-360X.2022.00236

34. Hu Q, Lu Y, Luo Y. Recent advances in dextran-based drug delivery systems: From fabrication strategies to applications. Carbohydr Polym. 2021;264:117999. https://doi.org/10.1016/j.carbpol.2021.117999 PMid:33910733

35. Petrovici AR, Pinteala M, Simionescu N. Dextran formulations as effective delivery systems of therapeutic agents. Molecules. 2023;28(3):1086. https://doi.org/10.3390/molecules28031086 PMid:36770753 PMCid:PMC9920038

36. Agrawal S, Budhwani D, Gurjar P, Telange D, Lambole V. Pullulan based derivatives: Synthesis, enhanced physicochemical properties, and applications. Drug Deliv. 2022;29(1):3328-3339. https://doi.org/10.1080/10717544.2022.2144544 PMid:36369833 PMCid:PMC9665098

37. Rashid A, Qayum A, Liang Q, Kang L, Ekumah JN, Han X, et al. Exploring the potential of pullulan-based films and coatings for effective food preservation: A comprehensive analysis of properties, activation strategies and applications. Int J Biol Macromol. 2024;260(Pt 2):129479. https://doi.org/10.1016/j.ijbiomac.2024.129479 PMid:38237831

38. Biswal S, Parmanik A, Das D, Sahoo RN, Nayak AK. Gellan gum-based in-situ gel formulations for ocular drug delivery: A practical approach. Int J Biol Macromol. 2025;290:138979. https://doi.org/10.1016/j.ijbiomac.2024.138979 PMid:39708866

39. Gomes D, Batista-Silva JP, Sousa A, Passarinha LA. Progress and opportunities in gellan gum-based materials: A review of preparation, characterization and emerging applications. Carbohydr Polym. 2023;311:120782. https://doi.org/10.1016/j.carbpol.2023.120782 PMid:37028862

40. Srivastava SK, Jha AK, Prasad M. Formulation, optimization and evaluation of gellan gum based in situ nasal gel of selegiline for depressive disorders. Int J Pharm Res. 2021;13(2):436-444. https://doi.org/10.31838/ijpr/2021.13.02.046

41.  Makwana M, Patani P, Paroha S. Natural polymer excipients: A green approach to multifunctionality in drug formulation. J Popul Ther Clin Pharmacol. 2025;32(7):1852-1861.

42. Abdulsalam L, Abubakar S, Permatasari I, Lawal AA, Uddin S, Ullah S, et al. Advanced biocompatible and biodegradable polymers: A review of functionalization, smart systems, and sustainable applications. Polymers. 2025;17(21):2901. https://doi.org/10.3390/polym17212901 PMid:41228661 PMCid:PMC12611034

43. Zhang H, Lin X, Cao X, Wang Y, Wang J, Zhao Y. Developing natural polymers for skin wound healing. Bioact Mater. 2023;33:355-376. https://doi.org/10.1016/j.bioactmat.2023.11.012 PMid:38282639 PMCid:PMC10818118

44. Martău GA, Mihai M, Vodnar DC. The use of chitosan, alginate, and pectin in the biomedical and food sector-Biocompatibility, bioadhesiveness, and biodegradability. Polymers. 2019;11(11):1837. https://doi.org/10.3390/polym11111837 PMid:31717269 PMCid:PMC6918388

45. Segneanu AE, Bejenaru LE, Bejenaru C, Blendea A, Mogoşanu GD, Biţă A, et al. Advancements in hydrogels: A comprehensive review of natural and synthetic innovations for biomedical applications. Polymers. 2025;17(15):2026. https://doi.org/10.3390/polym17152026 PMid:40808075 PMCid:PMC12349326

46. Dallaev R, Papež N, Allaham MM, Holcman V. Biodegradable polymers: Properties, applications, and environmental impact. Polymers. 2025;17(14):1981. https://doi.org/10.3390/polym17141981 PMid:40732859 PMCid:PMC12298952

47. Song R, Murphy M, Li C, Ting K, Soo C, Zheng Z. Current development of biodegradable polymeric materials for biomedical applications. Drug Des Devel Ther. 2018;12:3117-3145. https://doi.org/10.2147/DDDT.S165440 PMid:30288019 PMCid:PMC6161720

48. Yarahmadi A, Dousti B, Karami-Khorramabadi M, Afkhami H. Materials based on biodegradable polymers chitosan/gelatin: A review of potential applications. Front Bioeng Biotechnol. 2024;12:1397668. https://doi.org/10.3389/fbioe.2024.1397668 PMid:39157438 PMCid:PMC11327468

49. Rouaz K, Chiclana-Rodríguez B, Nardi-Ricart A, Suñé-Pou M, Mercadé-Frutos D, Suñé-Negre JM, et al. Excipients in the paediatric population: A review. Pharmaceutics. 2021;13(3):387. https://doi.org/10.3390/pharmaceutics13030387 PMid:33805830 PMCid:PMC8000418

50. Vroman I, Tighzert L. Biodegradable polymers. Materials (Basel). 2009;2(2):307-344. https://doi.org/10.3390/ma2020307 PMCid:PMC5445709

51. Prajapati V, Jani GK, Moradiya NG, Randeria NP. Pharmaceutical applications of various natural gums, mucilages and their modified forms. Carbohydr Polym. 2013;92(2):1685-1699. https://doi.org/10.1016/j.carbpol.2012.11.021 PMid:23399207

52. Basem Y, Ata A, Sabry F, Tamer M, Raaft E, Abdelmonem R. Sustainable green polymer production for pharmaceutical manufacturing: A review of environmental and economic impacts. Polymers. 2026;18(7):842. https://doi.org/10.3390/polym18070842 PMid:41977589 PMCid:PMC13075102

53. Pandit B, Saha P. Eco-friendly alternatives to conventional solvents: Innovations and applications in pharmaceutical manufacturing. Sustain Chem Clim Action. 2025;7:100140. https://doi.org/10.1016/j.scca.2025.100140

54. Pires PC, Mascarenhas-Melo F, Pedrosa K, Lopes D, Lopes J, Macário-Soares A, et al. Polymer-based biomaterials for pharmaceutical and biomedical applications: A focus on topical drug administration. Eur Polym J. 2023;187:111868. https://doi.org/10.1016/j.eurpolymj.2023.111868

55. Zhao L, Zhou Y, Zhang J, Liang H, Chen X, Tan H. Natural polymer-based hydrogels: From polymer to biomedical applications. Pharmaceutics. 2023;15(10):2514. https://doi.org/10.3390/pharmaceutics15102514 PMid:37896274 PMCid:PMC10610124

56. Parkash V, Maan S, Deepika, Yadav SK, Hemlata, Jogpal V. Fast disintegrating tablets: Opportunity in drug delivery system. J Adv Pharm Technol Res. 2011;2(4):223-235.   https://doi.org/10.4103/2231-4040.90877 PMid:22247889 PMCid:PMC3255350

57. Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: Mechanisms of controlling drug release. Chem Rev. 2016;116(4):2602-2663. https://doi.org/10.1021/acs.chemrev.5b00346 PMid:26854975 PMCid:PMC5509216

58. Kim Y, Park K, Kim MS. Recent advances in polymer-based drug delivery systems for atopic dermatitis: Enhancing therapeutic efficacy and outcomes. Mater Today Bio. 2025;35:102517. https://doi.org/10.1016/j.mtbio.2025.102517 PMid:41281660 PMCid:PMC12639611

59. Thang NH, Chien TB, Cuong DX. Polymer-based hydrogels applied in drug delivery: An overview. Gels. 2023;9(7):523. https://doi.org/10.3390/gels9070523 PMid:37504402 PMCid:PMC10379988

60. Biswas R, Kapat P, Ghosh A, Sarkhel S. Pharmaceutical polymers in drug delivery: An overview. Int J Pharm Pharm Sci. 2025;17(7):1-8. https://doi.org/10.22159/ijpps.2025v17i7.54498

61. Budiman A, Ivana H, Huang KA, Huang SA, Nadhira MS, Rusdin A, et al. Biocompatible natural polymer-based amorphous solid dispersion system improving drug physicochemical properties, stability, and efficacy. Polymers. 2025;17:2059. https://doi.org/10.3390/polym17152059 PMid:40808107 PMCid:PMC12349641

62. Mughal MA, Iqbal Z, Neau SH. Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride. AAPS PharmSciTech. 2011;12(1):77-87. https://doi.org/10.1208/s12249-010-9570-1 PMid:21174179 PMCid:PMC3066369

63. Kouchak M. In situ gelling systems for drug delivery. Jundishapur J Nat Pharm Prod. 2014;9(3):e20126. https://doi.org/10.17795/jjnpp-20126

64. Łętocha A, Miastkowska M, Sikora E. Preparation and characteristics of alginate microparticles for food, pharmaceutical and cosmetic applications. Polymers. 2022;14(18):3834. https://doi.org/10.3390/polym14183834 PMid:36145992 PMCid:PMC9502979

65. Ene Vatcu R, Iacob AT, Fulga I, Di Gioia ML, Dragostin I, Fulga A, et al. Hydrogels-Advanced polymer platforms for drug delivery. Polymers. 2026;18(6):709. https://doi.org/10.3390/polym18060709 PMid:41901842 PMCid:PMC13030644

66. Meyers RS. The past, present, and future of oral dosage forms for children. J Pediatr Pharmacol Ther. 2024;29(1):22-31. https://doi.org/10.5863/1551-6776-29.1.22 PMid:38332958 PMCid:PMC10849684

67. Logrippo S, Ricci G, Sestili M, Cespi M, Ferrara L, Palmieri GF, et al. Oral drug therapy in elderly with dysphagia: Between a rock and a hard place! Clin Interv Aging. 2017;12:241-251. https://doi.org/10.2147/CIA.S121905 PMid:28203065 PMCid:PMC5293185

68. Halasabalu Kalgeri S, Bheemasamudra Balaraj S, Shivakumar AT, Doddawad VG, Basapur Vijayakumar D, HS S, et al. Impact of polypharmacy on oral health in the elderly: Challenges and management. Front Dent Med. 2026;7:1758771. https://doi.org/10.3389/fdmed.2026.1758771 PMid:41809442 PMCid:PMC12968186

69. Remiro PFR, Nagahara MHT, Azoubel RA, Franz-Montan M, d’Ávila MA, Moraes ÂM. Polymeric biomaterials for topical drug delivery in the oral cavity: Advances on devices and manufacturing technologies. Pharmaceutics. 2022;15(1):12. https://doi.org/10.3390/pharmaceutics15010012 PMid:36678640 PMCid:PMC9864928

70. Syed Azhar SNA, Ashari SE, Zainuddin N, Hassan M. Nanostructured lipid carriers-hydrogels system for drug delivery: Nanohybrid technology perspective. Molecules. 2022;27(1):289. https://doi.org/10.3390/molecules27010289 PMid:35011520 PMCid:PMC8746478

71. Jacob S, Nair AB, Shah J, Sreeharsha N, Gupta S, Shinu P. Emerging role of hydrogels in drug delivery systems, tissue engineering and wound management. Pharmaceutics. 2021;13(3):357. https://doi.org/10.3390/pharmaceutics13030357 PMid:33800402 PMCid:PMC7999964

72. Kumar R, Islam T, Nurunnabi M. Mucoadhesive carriers for oral drug delivery. J Control Release. 2022;351:504-559. dhttps://doi.org/10.1016/j.jconrel.2022.09.024 PMid:36116580 PMCid:PMC9960552

73. Joshi S, Sheth S. Artificial intelligence (AI) in pharmaceutical formulation and dosage calculations. Pharmaceutics. 2025;17(11):1440. https://doi.org/10.3390/pharmaceutics17111440 PMid:41304779 PMCid:PMC12655709

74. Serrano DR, Kara A, Yuste I, Luciano FC, Ongoren B, Anaya BJ, et al. 3D printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals. Pharmaceutics. 2023;15(2):313. https://doi.org/10.3390/pharmaceutics15020313 PMid:36839636 PMCid:PMC9967161

75. Shao H, Liu M, Jiang H, Zhang Y. Polysaccharide-based drug delivery targeted approach for colon cancer treatment: A comprehensive review. Int J Biol Macromol. 2025;302:139177. https://doi.org/10.1016/j.ijbiomac.2024.139177 PMid:39798740

76. Kapoor DU, Pareek A, Uniyal P, Prajapati BG, Thanawuth K, Sriamornsak P. Innovative applications of 3D printing in personalized medicine and complex drug delivery systems. iScience. 2025;28(10):113505. https://doi.org/10.1016/j.isci.2025.113505 PMid:41035685 PMCid:PMC12481080

77. Xiong H, Yu LX, Qu H. Batch-to-batch quality consistency evaluation of botanical drug products using multivariate statistical analysis of the chromatographic fingerprint. AAPS PharmSciTech. 2013;14(2):802-810. -9966-9. https://doi.org/10.1208/s12249-013-9966-9 PMid:23636818 PMCid:PMC3665986

78. Ansari FA, Perazzolli M, Husain FM, Khan AS, Ahmed NZ, Meena RP. Novel decontamination approaches for stability and shelf-life improvement of herbal drugs: A concise review. The Microbe. 2024;3:100070. https://doi.org/10.1016/j.microb.2024.100070

79. Ng LH, Ling JKU, Hadinoto K. Formulation strategies to improve the stability and handling of oral solid dosage forms of highly hygroscopic pharmaceuticals and nutraceuticals. Pharmaceutics. 2022;14(10):2015. https://doi.org/10.3390/pharmaceutics14102015 PMid:36297450 PMCid:PMC9611293

80. Herdiana Y. Bridging the gap: The role of advanced formulation strategies in the clinical translation of nanoparticle-based drug delivery systems. Int J Nanomedicine. 2025;20:13039-13053. . https://doi.org/10.2147/IJN.S554821 PMid:41185748 PMCid:PMC12579833

81. Kanďárová H, Pôbiš P. The “big three” in biocompatibility testing of medical devices: Implementation of alternatives to animal experimentation-Are we there yet? Front Toxicol. 2024;5:1337468. https://doi.org/10.3389/ftox.2023.1337468 PMid:38259728 PMCid:PMC10800850

82. Parasuraman S. Toxicological screening. J Pharmacol Pharmacother. 2011;2(2):74-79. https://doi.org/10.4103/0976-500X.81895 PMid:21772764 PMCid:PMC3127354

83. Chang RK, Raw A, Lionberger R, Yu L. Generic development of topical dermatologic products: Formulation development, process development, and testing of topical dermatologic products. AAPS J. 2013;15(1):41-52. https://doi.org/10.1208/s12248-012-9411-0 PMid:23054971 PMCid:PMC3535108

84. Ong ES. Extraction methods and chemical standardization of botanicals and herbal preparations. J Chromatogr B. 2004;812(1-2):23-33. https://doi.org/10.1016/j.jchromb.2004.07.041 PMid:15556486

85. Rana YPS, Khan M. Pharmacopoeia: IP, BP, USP, NF and extra pharmacopoeia in India. In: Preliminary Pharmaceutics. Kaav Publications; 2023. p. 43-52. https://doi.org/10.52458/9788196830045.2023.eb.ch-06

86. Opriș O, Mormile C, Lung I, Stegarescu A, Soran ML, Soran A. An overview of biopolymers for drug delivery applications. Appl Sci. 2024;14:1383. https://doi.org/10.3390/app14041383

87. Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15(7):1916. https://doi.org/10.3390/pharmaceutics15071916 PMid:37514102 PMCid:PMC10385763

88. Ros H, Chan N, Cook MT, Shorthouse D. Artificial intelligence and machine learning guided optimization in drug delivery. Adv Drug Deliv Rev. 2026;232:115781. https://doi.org/10.1016/j.addr.2026.115781 PMid:41579967

89. Su J, Yang L, Sun Z, Zhan X. Personalized drug therapy: Innovative concept guided with proteoformics. Mol Cell Proteomics. 2024;23(3):100737. https://doi.org/10.1016/j.mcpro.2024.100737 PMid:38354979 PMCid:PMC10950891

90. Bertsch P, Diba M, Mooney DJ, Leeuwenburgh SCG. Self-healing injectable hydrogels for tissue regeneration. Chem Rev. 2023;123(2):834-873. https://doi.org/10.1021/acs.chemrev.2c00179 PMid:35930422 PMCid:PMC9881015

91. Zhang Y, Wu BM. Current advances in stimuli-responsive hydrogels as smart drug delivery carriers. Gels. 2023;9(10):838. doi:10.3390/gels9100838. https://doi.org/10.3390/gels9100838 PMid:37888411 PMCid:PMC10606589

92. Gheorghita R, Anchidin-Norocel L, Filip R, Dimian M, Covasa M. Applications of biopolymers for drugs and probiotics delivery. Polymers. 2021;13(16):2729. https://doi.org/10.3390/polym13162729 PMid:34451268 PMCid:PMC8399127

93. Donato L, Bernardo P. Polymeric membrane-based systems in transdermal drug delivery. Polymers. 2026;18(3):376. https://doi.org/10.3390/polym18030376 PMid:41682084 PMCid:PMC12899803

94. Menditto E, Orlando V, De Rosa G, Minghetti P, Musazzi UM, Cahir C, et al. Patient centric pharmaceutical drug product design-The impact on medication adherence. Pharmaceutics. 2020;12(1):44. https://doi.org/10.3390/pharmaceutics12010044 PMid:31947888 PMCid:PMC7023035

95. Račić A, Gatarić B, Topić Vučenović V, Stojmenovski A. Polysaccharide-based drug delivery systems in pediatrics: Addressing age-specific challenges and therapeutic applications. Polysaccharides. 2025;6:108. https://doi.org/10.3390/polysaccharides6040108